Home » Latest » Medical Technology » What we learned from building a medical technology startup | Fouad Al-Noor | TEDxTUBerlin

What we learned from building a medical technology startup | Fouad Al-Noor | TEDxTUBerlin

2

InfoSearched 70 Medical Technology

4.5

SaveSavedRemoved 0

Building a medical device is hard enough — getting it into a hospital is where most startups actually die.

At TEDxTUBerlin in May 2018, Fouad Al-Noor stood in front of an audience at Technische Universität Berlin and did something most startup founders avoid: he talked openly about failure modes. Al-Noor is the co-founder and CEO of ThinkSono, a London-based healthtech company building point-of-care ultrasound software, and his talk — “What we learned from building a medical technology startup,” later published by TED and running 10 minutes and 37 seconds — is less a victory lap than a survival manual for what he calls the “Medtech Valley of Death.” That’s the gap between a working prototype and a device hospitals will actually pay for and use.

• Al-Noor co-founded ThinkSono in late 2016 through the London cohort of the Entrepreneur First incubator (EF7), building software like ThinkSono Guidance to let non-specialist staff scan for deep vein thrombosis (DVT).
• His technical background spans a thesis on paper-based medical diagnostics using image processing at the University of Southampton, a software engineering stint at SAP in Palo Alto, and research work at Imperial College London on wearable EEG sleep-monitoring circuitry.
• The talk frames the “Medtech Valley of Death” as the specific gap between technical prototyping and commercial clinical adoption — driven by regulatory approval, clinical trial design, hospital procurement cycles, and data validation.

The Valley of Death, Defined

Al-Noor’s central argument is that medical technology doesn’t fail the way consumer software fails. A buggy app can ship an update overnight; a diagnostic tool that scans for DVT cannot. He walks through why so many technically sound devices never reach a patient: founders build something that works in a lab, then discover that “works” and “adoptable” are two entirely different bars in a hospital system built around procurement committees, liability, and multi-year purchasing cycles.

That distinction matters because it reframes what founders should be optimizing for early. Rather than treating regulatory approval as a finish line to sprint toward once the product is “done,” Al-Noor argues it has to be baked into the build from day one — alongside clinical trial design and the kind of data validation that convinces a hospital procurement officer, not just an engineer.

His Own Path Into the Problem

Al-Noor’s credibility on this comes from a specific, unusual résumé. Born in Iraq and raised in Norway, he studied Electronic Engineering with Nanotechnology at the University of Southampton, where his thesis tackled paper-based medical diagnostics using image processing — a direct precursor to the kind of accessible, low-cost screening tools he’d later build a company around. He then worked as a software engineer at SAP in Palo Alto before returning to the UK as a research assistant at Imperial College London, designing logging and power-optimization circuitry for wearable EEG devices used in sleep monitoring.

That combination — hardware, software, and hands-on clinical-adjacent research — is what he leaned on when he co-founded ThinkSono in late 2016 through the London cohort of Entrepreneur First (EF7). ThinkSono’s core bet is that point-of-care ultrasound shouldn’t require a radiologist in the room; its ThinkSono Guidance software is built to let non-specialist healthcare staff scan and screen for deep vein thrombosis, a condition that’s traditionally required specialist imaging to catch early.

Technical Efficacy Limits Project Success

The talk’s sharpest warning is aimed at founders who assume a good product sells itself. Al-Noor lays out the matrix that digital health startups have to navigate that consumer software simply doesn’t: device regulation, clinical trial design, procurement cycles, and data validation, all running in parallel and all capable of stalling a company that has otherwise built something that works.

Technical efficacy alone cannot overcome systemic friction without early clinical collaboration and structured execution.

That’s the crux of his framework: bring clinicians in early, not as a validation step at the end but as collaborators shaping the product from the start. It’s a lesson that echoes across the broader push documented in pieces like New Medical Technology In 2019, where the technologies that actually reach patients tend to be the ones built with clinical workflows in mind from the outset, not retrofitted onto them.

The Step-by-Step Framework

Al-Noor structures his advice as a sequence rather than a list of tips — start with the clinical problem, validate it with the people who’ll actually use the device, design for the regulatory pathway you’re targeting, and treat procurement as a design constraint rather than an afterthought. It’s a framework built specifically for the kind of ground covered in surveys like The Top 10 Most Promising Medical Technologies UPDATED, where promising tech and adopted tech are often two very different lists.

For founders building diagnostic tools specifically, he points to the same category of problem tackled by devices like the ones in New medical technology helps nurses insert an IV on the first try — tools that succeed because they’re designed around what a non-specialist clinician can actually do at the bedside, which is exactly the design principle behind ThinkSono Guidance’s push to let general staff run DVT scans without a radiologist present.

ThinkSono itself is Al-Noor’s live case study for the framework he’s describing — a company built specifically to get ultrasound-based DVT screening past the procurement and regulatory hurdles he spent his talk warning other founders about.